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ABSTRACT
Increased attention has been given to the gut lately in a number of conditions, from
maintaining health via the use of probiotics to treating Autism Spectrum Disorder. Parkinson’s
Disease has a history with the gut starting with the Braak hypothesis, in which eminent
researcher Heiko Braak observed that the spread of Parkinson’s (PD) seemed to occur along
either olfactory or enteric neurons prior to reaching the substantia nigra in the midbrain, where
the classical disease symptoms become evident. Though this finding was largely ignored at the
time, the possibility of a gut origin for PD has received interest lately as a growing body of
epidemiological and mechanistic research supports a gut-based influence. One key study showed
that the presence of a toxin that induces oxidative stress in the intestine is capable of generating
protein aggregates that spread to the brain and cause a PD-like pathology. The spread of protein
aggregates from gut neurons to the brain has been corroborated in a number of studies. The open
question, then, is what type of toxic triggers are capable of causing protein aggregation in the
real world, and how do they cause protein aggregation in enteric neurons, which do not directly
contact the intestinal lumen? We propose here that the enzyme Nox1 contributes to oxidative
stress in the gut and eventually to the protein aggregation that can lead to PD via the generation
of endogenous reactive oxygen species. Nox1 functions to generate superoxide radicals and is
highly expressed in the colon. Knockdown of NOX1 in the brain has been shown to have a
protective effect in a PD mouse model. To bridge a trigger in the intestinal lumen to protein
aggregation in enteric neurons, we investigate a class of cells that contact both the intestinal
lumen and enteric neurons, known as enteroendocrine cells. Finally, we conduct a small study to
explore a possible toxic trigger, high fat diet.

ii

ACKNOWLEDGMENTS
I would like to thank Dr. Kim for his continued guidance throughout the thesis process,
as well as my committee members, Dr. Yooseph and Dr. Southwell, for their patience and
support. I also want to acknowledge the Burnett Honors College for supporting this research
through the Honors in the Major Scholarship.

iii

TABLE OF CONTENTS

LIST OF FIGURES………………………………………………………………………..……...v
LIST OF ACRONYMS/ABBREVIATIONS…………………………………………….………vi
INTRODUCTION…………………………………………………………………………...……1
RESULTS……………………...………………………………………………………………….9
MATERIALS AND METHODS…………………………………………………………...……17
DISCUSSION….………………………………………………………………………...………21
REFERENCES…………………………………………………………………………..………22

iv

LIST OF FIGURES
Figure 1: Nox1 protein structure......................................................................................................7
Figure 2: Schematic of proposed relationship between Nox1 and PD in gut..................................8
Figure 3: Alpha synuclein and Nox1 transcript expression in young and aged mice....................10
Figure 4: Nox1 IHC staining in young and aged mice...................................................................12
Figure 5: Alpha synuclein and Nox1 transcript expression in STC-1 cells...................................14
Figure 6: Nox1 IHC staining on HFD mouse intestinal tissue......................................................16

v

LIST OF ACRONYMS/ABBREVIATIONS
PD – Parkinson’s Disease
HFD – High Fat Diet
OS – Oxidative Stress
ROS – Reactive Oxygen Species
Nox1 – NADPH Oxidase 1
SN – Substantia Nigra
EEC – Enteroendocrine Cell
PQ - Paraquat
MPTP – 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
6-OHDA – 6-Hydroxydopamine
IHC – Immunohistochemistry
PCR – Polymerase Chain Reaction
2ab – Secondary Antibody
LPS – Lipopolysaccharide
TH – Tyrosine Hydroxylase
a-SYN – Alpha Synuclein

vi

INTRODUCTION
Parkinson’s Disease (PD) is the second most common neurodegenerative disease,
affecting about 1% of the population over 60 and then again to 4% for those over 80 (1). The
disease is typically characterized by the progressive loss of dopaminergic neurons in a region of
the brain known as the substantia nigra or “black substance” (2). Post-mortem analysis of PD
brains reveals the only physical hallmark of the disease, insoluble inclusions known as Lewy
Bodies present throughout affected brain regions (2). Patients with PD typically present with two
of four cardinal symptoms of PD, which include resting tremor, bradykinesia, rigidity, and
postural instability (2). The diagnosis of PD is made based on these symptoms, patient history,
and the United Parkinson’s Disease Rating Scale (2).
The etiology of PD is obscure. Overall, about 80-90% of PD cases are considered
idiopathic, meaning that the cause is unknown, and the other approximately 10-20% of cases are
linked to genetics (2). In certain cases, the environment seems to play the dominant role, and
likely accounts for some of those “idiopathic” cases. For example, exposure to pesticides like
rotenone and paraquat increase PD risk by about 70%, and these same pesticides are used in the
lab to generate in vivo and in vitro models of PD since they can recapitulate many of the
symptoms and molecular aspects of the disease (3). On the other hand, genetics can also play a
major role. Autosomal dominant mutations in LRRK2 and autosomal recessive mutations in DJ-1
often result in early-onset PD (2). Despite the many gene loci identified with PD risk and the
cases where the environment is known to play a role, the explicit cause of PD in the majority of
the cases is unknown.
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Briefly, there is one protein that deserves special attention with respect to PD pathology:
alpha synuclein (4). Alpha synuclein plays a central role in PD and is extensively studied. The
interest for this protein is derived from the fact that it makes up a major component of Lewy
Bodies, and causes early onset PD in a dose-dependent manner (4). That is, duplications in
SNCA, the gene for alpha-synuclein, cause early onset PD, and triplications of SNCA result in
even earlier onset PD (4). At the molecular level, alpha synuclein is thought to contribute to PD
when it takes on a beta-sheet conformation instead of its usual alpha helix, which allows it to
aggregate into toxic oligomers, while also inducing other alpha synuclein species to fold into
beta sheets as well (4). For this reason, alpha synuclein aggregation is referred to as “prion-like”
(4). In fact, not only does alpha synuclein spread in a prion-like fashion inside the cell, but it can
propagate between cells too. One relatively recent study found that, when PD brains were grafted
with stem cells, these new stem cells also developed alpha synuclein aggregates within a matter
of years (5).
Recently, mounting evidence has suggested a role for the gut in PD pathogenesis. The
foundation for this hypothesis comes from several observations. First, non-motor symptoms of
PD, namely constipation, pre-date the motor symptoms by several years (6). As a result,
constipation is thought to indicate an early stage of PD pathology, presumably one in which
enteric nerves have been damaged by the spread of the disease. Second, alpha synuclein
aggregates have been shown to be able to propagate up the vagus nerve to the brain (6). Next, a
large study found that patients that had undergone vagotomy were 50% less likely than controls
to develop PD (6). Interestingly, the effect was noted only for truncal vagotomy (entire vagus
nerve severed) and not for superselective vagotomy (only specific branches of the nerve severed)
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(6). This research suggests what is known as “the gut hypothesis for PD”, which posits that a
toxic insult in the intestines causes a change in enteric neurons that initiates alpha synuclein
aggregation, the aggregates then spread in a prion-like fashion up the vagus nerve into the brain,
and finally the alpha synuclein aggregates reach the substantia nigra (SN) and induce the motor
symptoms that define the disease (6).
In a parallel vein, it is also vital to consider the role that oxidative stress (OS) plays in PD
pathology. OS plays a central role in the pathology of many neurodegenerative diseases,
including PD (17). In PD specifically, the importance of OS can be illustrated by its core
involvement in the major toxin models used to replicate PD pathology including Paraquat, 6OHDA, MPTP, and Rotenone (18,19). In addition, genetic forms of PD often have some
relatedness to OS (18,19). For example, LRRK2 mutations are related to mitochondrial
dysfunction, and DJ-1 is a quencher of reactive oxygen species (ROS) that is protective against
6-OHDA (18,19). The mechanisms whereby OS would lead to dopaminergic cell death include
damage to the ubiquitin-proteasome system, lipid peroxidation, DNA damage, protein damage,
alpha synuclein aggregation, and mitochondrial dysfunction (20). There is then the problem of
trying to discern whether OS causes or contributes to PD pathogenesis. The issue is that many of
the toxic effects that can be mediated by OS can also cause OS themselves (20). Alpha synuclein
aggregation, for example, results in the production of ROS that contributes to OS, which can
then further contribute to alpha synuclein aggregation (19). Mitochondrial dysfunction results in
ROS generation that can lend an OS environment, and this OS can then further cause
mitochondrial damage (20). Still, OS is involved in most parts of the PD disease process, and
seems feasible as a primary event that could initiate alpha synuclein aggregation and other
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aspects of PD pathology, or at the very least contribute to disease susceptibility. A 2010 study
showed that low doses of rotenone delivered intragastrically over long periods of time could
generate alpha-synuclein aggregates in neurons that spread from the vagus nerve up to the SN in
a mouse model (16). In this study, it is important to consider that rotenone, a mitochondrial
inhibitor and potent inducer of OS, started at the intestinal lumen before diffusing into cells and
somehow initiating alpha synuclein aggregation in neurons (16). There are no neurons directly
lining the intestinal lumen (15).
Though intestinal epithelial cells themselves are an unlikely candidate for initiators of PD
pathology due to their fast turnover time, enteroendocrine cells (EECs) are an attractive choice
(15). These cells are sparsely distributed throughout the intestinal tract, and line the intestinal
lumen just like intestinal epithelial cells, and so are exposed to whatever environment is present
there (15). EECs also have a much longer turnover time compared to intestinal epithelial cells,
which is important because OS may take time to initiate alpha synuclein aggregation (15).
Importantly, EECs express alpha synuclein (15). Lastly, EECs directly contact neurons, which is
an essential feature if they are expected to initiate PD pathology that eventually spreads to the
brain (15). Once alpha synuclein aggregates reach enteric neurons, it has already been
established that alpha synuclein can spread up the vagus nerve to the brain (16). What is
currently not known is how aggregates can get to enteric neurons from inside the intestinal
lumen.
As a prominent generator of OS that is highly expressed in intestinal epithelial cells, and
a protein that has been previously implicated in PD, Nox1 seems like a plausible contributor to
intestinal PD pathology (21). The Nox family of NADPH oxidases were among the first enzymes
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discovered that generate ROS “intentionally,” and not simply as a byproduct of some other
process like ATP production in mitochondria (21). Nox2 was the first isoform identified, where
it was found to play a role in the respiratory burst and pathogen destruction by phagocytes (21).
Today, there are a variety of Nox enzymes known with numerous roles in various tissues (21).
Of the several Nox isoforms, Nox1 is highly expressed in the colon, where it was originally
cloned (22). Namely, Nox1 is present in colon epithelial cells, and it confers these cells with the
ability to produce superoxide (see Figure 1) (22). The role of superoxide generation in these
intestinal epithelial cells is thought to either facilitate cell proliferation or act as part of the host
response (22). With respect to the host response hypothesis, Nox1 expression is correlated with
areas of increased bacterial colonization, and its expression is increased by exposure to
interferon-gamma, lipopolysaccharide, and flagellins (22). Moreover, it was found that intestinal
epithelial cells rapidly respond to commensal or pathogenic microbes with ROS, likely through a
Nox1/Duox2 mediated pathway since these enzymes are highly expressed in intestinal epithelial
cells (12).
With respect to PD, Nox1 in the brain was implicated in PD pathology in a number of
studies by our lab (23, 24, 25). In a rat 6-hydroxydopamine (6-OHDA) PD model, Nox1
expression was shown to increase in the SN along with DNA oxidative stress (23). In a second
study, Nox1 expression was found to increase in a paraquat (PQ) mouse model of PD, and Nox1
inhibition protected Tyrosine Hydroxylase-positive neurons from death in the SN (24). Last,
Nox1 knockdown in a PQ rat model of PD was sufficient to reduce Tyrosine Hydroxylasepositive neuron cell death, OS, and alpha synuclein oligomers in the SN (25).
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Finally, we investigated high fat diet (HFD) as a possible trigger for PD-related
pathology in the gut. First, one study showed that PD patients have an increase in their overall
caloric intake, with the most major change occurring with intake of fats (26). Next, in a 1methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD, mice fed a HFD had
lower dopamine levels after treatment and more striatal neuron loss (27). In another study it was
shown that mouse fed a HFD prior to being subject to a 6-OHDA model of PD had increased
dopaminergic (DA) cell loss as well as increased oxidative stress in the SN (28). Fat intake on
the whole has also been show to increase the amount of oxidative stress in the gut (29).
Moreover, long-term ingestion of HFD leads to changes in the microbiome (30). A major study
related the microbiome to PD by showing that, in an alpha synuclein overexpression model of
PD in mice, PD motor symptoms were largely attenuated in germ-free mice (31). Additionally,
the study found that microbiome transplant from PD-affected human donors exacerbated
physical symptoms when compared to transplant from healthy donors in the overexpression
mouse model (31). An overall schematic showing the proposed relationship between an intestinal
trigger like HFD, Nox1, OS, and alpha synuclein aggregation is shown in Figure 2.

xii6

Figure 1: Depiction of Nox1 protein generating superoxide while oxidizing NADPH to
NADP+. Also shown are the many subunits associated with Nox1. Cytosolic subunits
NOXA1 and NOXO1 are required for superoxide generation. Image from Ma et al,
Molecular Neurodegeneration
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Figure 1: Schematic depicting proposed relationship between intestinal trigger, Nox1, OS, and alpha
synuclein aggregation. Intestinal changes initiated by trigger cause EECs contacting the lumen to
upregulate expression of Nox1. OS is generated as a result, initiating alpha synuclein aggregation within
the EECs. Alpha synuclein aggregates spread from the EECs to enteric neurons contacting the EECs.
From there, aggregates spread to the vagus nerve and finally to the substantia nigra.
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RESULTS
Nox1 and Alpha Synuclein Transcripts are Present in Young and Aged Mouse Colon
Duodenum, ileum and colon tissues were collected from a 7-month old male mouse, a 7month old female mouse, and a 23-month old male mouse. After that, RNA was extracted using
Trizol. cDNA was then synthesized from the RNA, and a Polymerase Chain Reaction (PCR)
using the cDNA as template was carried out. Primers for Nox1, alpha synuclein, and GAPDH
were used (Figure 3).
This experiment was performed because age is the most significant risk factor for PD,
and therefore the presence of Nox1 in aged mice would be helpful in building our hypothesis
(32). In addition, oxidative stress is known to increase with age, and an upregulation in Nox1
expression was shown to occur in response to a toxin that induces oxidative stress in the brain in
a previous study by our lab (32, 25). This result suggests that Nox1 is present throughout the
intestinal tract in mice of both 7 and 23 months of age. It also suggests that alpha synuclein is
present in at least the colons of male and female mice of both 7 months and 23 months of age,
but it is not consistently detectable in the ileum and duodenum of 7-month old mice.
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Figure 3: PCR data from cDNA of Duodenum, Ileum, and Colon of 7-month old male mouse, 7-month old
female mouse, and 23-month old male mouse.
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Nox1 Protein is Present throughout the Intestines of Young and Aged Mice
Intestinal tissues from duodenum, ileum, and colon were extracted from a 7-month old
male mouse and a 23-month old male mouse. Immunohistochemistry (IHC) was then performed
on these tissues using Nox1 as the primary antibody. A secondary antibody control, in which
only secondary antibody and no primary antibody was used, was performed to establish
background staining. Following IHC, 5x, 10x, and 40x images were taken of the tissues.
Representative 10x images are shown below (Figure 4).
The expectation was that Nox1 protein levels would be present throughout the intestinal
tract, but that Nox1 expression would be highest in the colon. Moreover, we were expecting to
see that Nox1 levels would be significantly greater in the colon of the aged mouse when
compared to the young mouse. We were able to confirm that Nox1 is in fact expressed thoughout
the intestinal tract of both young and aged mice, but it is unclear from this study if there is
increased expression in the colon or in the intestines of aged mice.
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Dr. Basu, unpublished

Figure 4: IHC of Duodenum, Ileum, and Colon from a 7-month old male mouse mouse and a 23-month
old male mouse. “2ab” indicates that only secondary antibody was used, which acted as a control for
background staining.
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STC-1 Cells Express Alpha Synuclein and Nox1 Transcripts
STC-1 cells were treated with either Dimethyl sulfoxide (DMSO) (vehicle control),
100nM of Rotenone or 500nM of Rotenone and collected after 48 hours. The cells then
underwent RNA extraction, and cDNA was subsequently synthesized from the RNA. Finally, the
cDNA was amplified via PCR using Nox1, alpha synuclein, and GAPDH primer sets (Figure 5).
In a previous study by our lab, it was shown that N27 cells (rat dopaminergic neuron cell
line) treated under similar conditions exhibited an increase in Nox1 and alpha synuclein
transcript expression (25). It was unclear in the literature whether or not STC-1 cells express
Nox1 transcripts. In this experiment, it appears that they do. We also observed in this trial that
STC-1 cells express alpha synuclein transcripts, as had been previously reported.
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Figure 5: PCR of alpha synuclein and Nox1 cDNA in STC-1 cells under DMSO, 100nM Rotenone and 500nM
Rotenone after 48 hours.
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Nox1 Protein Levels are Unchanged in the Intestinal Tissue of Young Mice Fed a HFD
Seven mice fed a HFD for 24 weeks were compared to six age-matched mice fed a
normal chow diet. Intestinal tissue was collected at the end of the 24 weeks and paraffinembedded. Tissue was then sliced using a microtome and dried onto a microscope slide to be
used in IHC staining. Nox1 antibody was used as the primary antibody in this study. 5x, 10x,
and 40x images were taken of DAB-stained slides following IHC. Representative 10x images
from three control and three HFD mouse tissues are shown below (Figure 3). Image
quantification was performed using ImageJ on the 10x images for each tissue.
In this case, HFD was investigated as a possible trigger that could enhance Nox1 protein
expression in a Nox1-mediated PD model. If HFD did act as a trigger, it would be expected that
a significant increase in Nox1 expression could be observed, especially in the colon, where Nox1
protein levels are the highest. It does not appear here that there was any change in Nox1 protein
level expression in HFD intestinal tissues compared to controls.
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Figure 6: Representative micrographs from Nox1 staining of the intestinal tissues of three animals each in
either a HFD or Control diet. Duodenum (top left), ileum (top right), and colon (center) sections are
shown with animals in the Control diet group in the top row and animals in the HFD group in the bottom
row.
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MATERIALS AND METHODS
STC-1 Cell Culture Maintenance
STC-1 cells (ATCC) were maintained above five passages in DMEM high glucose
supplemented with 20% FBS. Cell splitting was achieved by first incubating cells with TrypsinEDTA (TE) for 1-2 minutes, inactivating the TE by addition of equal volume of culture media,
and pelleting the cells by 5 minutes of centrifugation at 500xg. The supernatant was then
aspirated and the pellet resuspended in 1ml of media. This cell suspension was then aliquoted in
appropriate volumes to new culture dishes or the same dish for the desired amount of cell
splitting.

RNA Extraction
RNA extraction was performed using 500ul of Trizol reagent (Invitrogen) for STC-1 cell
pellets and 1ml Trizol reagent for tissue samples. Cell pellets and tissue samples were
homogenized by pipetting up and down using a p1000. A p200 was used if further dissociation
was required. For the tissue samples, even after pipetting and prolonged incubation in Trizol,
some material did not dissolve. In this case, samples were spun down as 12,000xg for 10 minutes
at 4°C, and the supernatant was collected and transferred to a new 1.5ml tube. After that, the
RNA extraction proceeded as described in the Invitrogen protocol. Following extraction, the
RNA pellet was allowed to dry in a 1.5ml tube with the lid open for 20 minutes. Samples were
resuspended in 30ul to 50ul DEPC-treated water depending on pellet size.
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cDNA Synthesis
cDNA synthesis consisted of using the GenDEPOT amfiRivert cDNA Synthesis Platinum
Master Mix. A mixture was prepared consisting of 1ug of RNA brought up to a volume of 9ul
with DEPC water, 10ul of a 2X buffer, and 1ul of reverse transcriptase enzyme. The reaction
mixture was then incubated in a thermocycler at the following conditions: 1 minute at 60°C, 5
minutes at 25°C, 1 hour at 50°C, and 1 minute at 85°C.

Polymerase Chain Reaction
PCR was carried out using the GenDEPOT amfiSure PCR Master Mix (2X). The total
reaction volume used was 16ul, and it contained 8ul of the 2X Master Mix, 1ul of 10uM forward
primer, 1ul of 10uM reverse primer, 1ul of template DNA and 5ul of PCR-certified water.
Following amplification, DNA amplicons were analyzed via agarose gel electrophoresis. A 1.2%
agarose gel with 0.5ug ethidium bromide per 1ml agarose was typically used, and the gel was run
at 100V for approximately 30 minutes. Depending on the amount of samples involved, gels were
either prepared to a volume of 75ml or 150ml. Following electrophoresis, agarose gels were
imaged in a Gel Doc Easy Imager (Biorad) with 0.2 seconds of light exposure.

Immunohistochemistry
Paraffin-embedded tissues were cut to 25 micron slices using a microtome and then
placed on microscope slides. Tissue slices on slides were allowed to dry overnight. After that,
slides were deparaffinized in 2 changes of xylene for 5 minutes each, followed by incubation in
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2 changes of 100% ethanol for 3 minutes each, 95% ethanol for 1 minute, and 80% ethanol for 1
minute. All slides were then boiled at 95-100°C in Sodium Citrate Buffer (10mM Citric Acid,
0.05% Tween 20, pH 6) for 30 minutes. The slides were then allowed to cool for 20 minutes, and
then rinsed twice in PBS-T (PBS with 0.05% Tween 20) for 5 minutes each. Endogenous
peroxidase blocking was achieved by incubating slides in 3% hydrogen peroxide in PBS for 5
minutes. Slides were rinsed in PBS-T and then permeabilized in 0.2% Triton in PBS. Next,
blocking was performed in a solution of 1% Bovine Serum Albumin (BSA) and 5% horse serum
in PBS-T for 30 minutes. Samples were washed in PBS-T and then incubated in primary
antibody overnight at 4°C in a humidifier. Primary antibody staining was performed using a 1:25
dilution of Nox1 antibody serum (a gift from the lab of Yabe-Nishimura). The next day, samples
were washed three times in PBS-T and secondary antibody coupled to biotin was applied for one
hour. Slides were washed again with PBS-T and then slides were incubated in the Avidin-Biotin
Complex Reagents (Vecta Stain) for 1 hour. The samples were washed in 0.1M PB and then
DAB stain (0.7mg/1mL DAB in a solution of 30% hydrogen peroxide and 0.1M PB) was applied
for 2 minutes to each samples, in set of three slides at a time. After that, all slides were
dehydrated by immersing in dH2O for 5 minutes, 70% ethanol for 5 minutes, 80% ethanol for 5
minutes, 90% ethanol for 5 minutes, and 2 changes of 100% ethanol or 5 minutes. The samples
were then placed in xylene for 15 minutes and mounted on a coverslip using Permount. The
coverslips were allowed to dry overnight before being visualized on a Leica microscope.
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Aged Mouse Studies
Wild Type (WT) C57BL/6 mice were used in these studies, including a 7-month old male
mouse, a 7-month old female mouse, and a 23-month old male mouse.

High Fat Diet Treatment
WT C57BL/6 mice were fed a 60% HFD for 24 weeks. All mice were 32 weeks (8
months) old. Body weight and food intake for each mouse was monitored on a weekly basis. The
control group in the study consisted of three females and three males, and the HFD group
consisted of four females and three males.
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DISCUSSION
It is difficult to come to any concrete conclusions with the data obtained here, as much of
it needs to be repeated. However, the data seems to suggest that Nox1 transcripts and protein are
in fact present throughout young and aged mouse colons. It also seems that alpha synuclein
transcripts exist in STC-1 cells. Also in STC-1 cells is the suggestion that Nox1 transcripts
exists. If this observation is proven to be true after repeated experiments, it would simplify our
downstream in vitro experiments in that a co-culture of STC-1 cells and intestinal epithelial cells
would not be necessary. Finally, feeding mice a HFD does not appear to affect Nox1 protein
levels in the intestinal tract. To confirm this, it may be necessary to further explore the
functionality of ImageJ and find a way to measure staining in specific structures, as opposed to
measuring overall staining.
The data shown here represent only the very beginning steps of a long study involving
Nox1’s role as a mediator of gut pathology. As stated above, many more repeats of the data
shown here will be needed. Also down the road, larger cohorts will be necessary to generate
findings that are meaningful. Moreover, other experiments may be used, including western blots
and qPCR, to evaluate differences in transcript and protein expression.
Finally, in the future, we may continue to investigate HFD as a possible trigger for Nox1mediated PD pathology in the gut, despite its apparent lack of a connection to Nox1 in this initial
study. More focus, however, will be devoted to investigating P. mirabilis as a possible mediator
of gut pathology, based on the study by Choi et al (34).
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